Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen
- PMID: 15172987
- DOI: 10.1158/0008-5472.CAN-03-3852
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen
Abstract
We have generated DNA methylation profiles of 148 human breast tumors and found significant differences in hormone receptor (HR) status between clusters of DNA methylation profiles. Of 35 DNA methylation markers analyzed, the ESR1 gene, encoding estrogen receptor alpha, proved to be the best predictor of progesterone receptor status, whereas methylation of the PGR gene, encoding progesterone receptor, was the best predictor of estrogen receptor status. ESR1 methylation outperformed HR status as a predictor of clinical response in patients treated with the antiestrogen tamoxifen, whereas promoter methylation of the CYP1B1 gene, encoding a tamoxifen- and estradiol-metabolizing cytochrome p450, predicted response differentially in tamoxifen-treated and nontamoxifen-treated patients. High levels of promoter methylation of the ARHI gene, encoding a RAS-related small G-protein, were strongly predictive of good survival in patients who had not received tamoxifen therapy. Our results reveal an as yet unrecognized degree of interaction between DNA methylation and HR biology in breast cancer cells and suggest potentially clinically useful novel DNA methylation predictors of response to hormonal and non-hormonal breast cancer therapy.
Similar articles
-
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31. Breast Cancer Res Treat. 2009. PMID: 18668363 Clinical Trial.
-
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.Cancer Res. 2005 May 15;65(10):4101-17. doi: 10.1158/0008-5472.CAN-05-0064. Cancer Res. 2005. PMID: 15899800
-
Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.Anticancer Res. 2006 May-Jun;26(3A):1773-84. Anticancer Res. 2006. PMID: 16827106
-
[Progesterone receptor in breast cancer: fundamental data and clinical applications].Bull Cancer. 1996;83 Suppl 1:1-5. Bull Cancer. 1996. PMID: 8777338 Review. French. No abstract available.
-
Can hormone "resistant" breast cancer cells be inappropriately stimulated by tamoxifen?Ann N Y Acad Sci. 1993 Jun 11;684:63-74. doi: 10.1111/j.1749-6632.1993.tb32271.x. Ann N Y Acad Sci. 1993. PMID: 8317847 Review.
Cited by
-
Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.Neoplasia. 2006 Jun;8(6):458-64. doi: 10.1593/neo.06247. Neoplasia. 2006. PMID: 16820091 Free PMC article.
-
Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.Neoplasia. 2007 Jul;9(7):569-77. doi: 10.1593/neo.07334. Neoplasia. 2007. PMID: 17710160 Free PMC article.
-
Epigenetic modification of gene expression in cancer cells by terahertz demethylation.Sci Rep. 2023 Mar 26;13(1):4930. doi: 10.1038/s41598-023-31828-w. Sci Rep. 2023. PMID: 36967404 Free PMC article.
-
Effect of estrogen receptor α binding on functional DNA methylation in breast cancer.Epigenetics. 2014 Apr;9(4):523-32. doi: 10.4161/epi.27688. Epub 2014 Jan 16. Epigenetics. 2014. PMID: 24434785 Free PMC article.
-
High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.J Mol Diagn. 2009 Mar;11(2):102-8. doi: 10.2353/jmoldx.2009.080109. Epub 2009 Jan 29. J Mol Diagn. 2009. PMID: 19179456 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous